DNAprint Genomics (DNAG)

[stakddek]

This is some very dated info on Orphan Drugs. The EU and even our FDA seem to allow a special status and certain allowances for medicines, drugs, tailored for a limited population.

++++++++++++++++++++++

http://www.europarl.eu.int/stoa/publi/167780/default_en.htm

++++++++++++++++++++++

I would presume that many drugs are beneficial for limited populations, but are economically infeasible for "large pharma" to devote in house resources to. Now if there was an outsourcing method, to effectively find the population most likely to benefit economically.... Well better a few bucks coming in than just a write off as a failed avenue.

Stakddek